K & H Pharma 4

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: LULegal Form: 8888

ACTIVE

LEI: 22210016YTQZ14H6E478

Summary

K & H Pharma 4 is an organization. It is a subsidiary of KBC Asset Management.

Legal entity: GLEIF